Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral N-acetylcysteine for acute decompensated heart failure
ACTRN12611000766910Phase 2Recruiting
- Sponsor
- Alfred Health
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in heart failure (HF), sponsored by Alfred Health. Started Jan 2011; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12611000766910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000766910.